The Aneurysm Therapeutics Market is expected to register a CAGR of 7.80% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report presents an analysis based on by Product Type ( Medicine, Surgery, Other Types ). The report further provides analysis based on End User ( Hospitals, Clinics, Other End Users ). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Aneurysm Therapeutics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Aneurysm Therapeutics Market Segmentation
Type- Medicine
- Surgery
- Other Types
- Hospitals
- Clinics
- Other End Users
Strategic Insights
Aneurysm Therapeutics Market Growth Drivers- Innovative Reflections in Healthcare Imaging Technology: Advanced imaging modalities such as high-resolution magnetic resonance imaging (MRI) and computed tomographic scans now make it possible to diagnose aneurysms earlier, surveil their growth, locate them, and measure their size so individualized treatment approaches can be formulated. Then, it follows that with the more advanced imaging technology, the more need there is to create new therapeutics, thereby driving the markets for aneurysm treatment.
- Establishes the Growing Aging Population: The global increase in elderly individuals has contributed to an increase in such age-related diseases as aneurysms. Older people are more professionals developing an aneurysm, especially in their aorta and brain; as this population increases, the need for treatment continues, so it increases market demands for surgery- and drug-based treatments for the growing burden of aneurysms.
- New Breakthroughs in Minimally Invasive Procedures: These techniques include endovascular repair of aneurysms (EVAR), which facilitate the development of alternatives to the classical procedure that are both safe and quicker for a patient to recover from. These techniques are characterized by smaller incisions coupled with reduced complication risks and shorter hospital stays. They keep evolving, attracting patients and health-care providers seeking efficient and less invasive approaches to therapy.
- Personalization in Aneurysm Therapy: Treatment extricates the possible development with regards to treatment individualized according to the personal genetic profile of the patient and the injury risks. Thus, clinicians will rely more intensively on biomarker and advanced diagnostics to augment their capacity to predict better the risk of an aneurysm rupture and customize interventions. It is most likely to stimulate the invention of medications and therapies specifically intended for improved outcomes predicted by decreased therapy risks.
- Emerging Applications of Artificial Intelligence Technology in Diagnosis: Artificial intelligence (AI) enhances the speed and efficiency by which an aneurysm can be identified, via imaging, and it improves the process of "scanning" by identifying façades that escape some, or even all, of the human experts. The synergies realize new possibilities from between advanced therapies and diagnosis to produce a revolution that improves prevention and treatment schemes and, consequently, the market on therapeutics.
- Increased Attention Towards Endovascular Devices: There is a general shift in favor of endovascular devices such as stent grafts and coils in the treatment of an aneurysm. Such devices are minimally invasive with shorter recovery times and lower complication rates when compared to conventional open surgeries. With the fast changing technology, these methods are expected to dominate the market for aneurysm therapeutics with ongoing developments in device materials and techniques that will focus on improvement of treatment efficacy.
- New Biological Therapies: Currently, approaches for biologic therapy, such as gene editing or stem-cell therapies, are among the most promising forms of aneurysm treatment. These methods might tend to reverse the very causative agents behind the aneurism--such as mutation and/or degenerative changes in the tissue--much more specifically and effectively than any other treatment possible through conventional means. Advance much, much more biologics for maximum outcome and reach among customers.
- Emergence in Developing Economies: Manifold growth trends will be seen in the developing nations. Improvements in health and medical infrastructure will increase the aneurysm therapeutics market. Moreover, new diagnoses in access to care in such countries in Asia, Latin America, and Africa are beginning to attract attention to advanced techniques; hence part of those lives can be saved to create massive market opportunities for the pharmaceutical companies and device manufacturers to market affordable therapies into underserved populations as this market will increase.
- Advancements of Drug Delivery System: Drug delivery systems that can be interfaced with the high technology like the targeted nanoparticles or those that are formulated for a sustained release can increase the potential of aneurysm therapeutics. This would facilitate drug administration directly to the site of the aneurysm so that release is controlled, thereby lowering side effects while maximizing therapeutics. It can also provide good patient adherence, which makes this an exciting area in the market for future growth.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Aneurysm Therapeutics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Aneurysm Therapeutics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Aneurysm Therapeutics Market is estimated to witness a CAGR of 7.80% from 2023 to 2031
The major factors driving the Aneurysm Therapeutics market are:
1.Increasing Prevalence of Cardiovascular Diseases
2. Government Initiatives and Funding
3. Improved Surgical Techniques
North America region dominated the Aneurysm Therapeutics market in 2023
Asia Pacific region dominated the Aneurysm Therapeutics market in 2023
The Left Ventricular Assist Devices (LVAD)
segment accounts for highest revenue in product the Aneurysm Therapeutics market in 2023
SynCardia Systems, Cleveland Heart, Inc., BiVACOR Inc., Abbott accounting for higesh market shares and are some of the major players operating in the market
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Aneurysm Therapeutics Market - By Type
1.3.2 Aneurysm Therapeutics Market - By End User
1.3.3 Aneurysm Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANEURYSM THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANEURYSM THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANEURYSM THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANEURYSM THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. ANEURYSM THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANEURYSM THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MEDICINE
7.3.1. Overview
7.3.2. Medicine Market Forecast and Analysis
7.4. SURGERY
7.4.1. Overview
7.4.2. Surgery Market Forecast and Analysis
7.5. OTHER TYPES
7.5.1. Overview
7.5.2. Other Types Market Forecast and Analysis
8. ANEURYSM THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. ANEURYSM THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Aneurysm Therapeutics Market Overview
9.1.2 North America Aneurysm Therapeutics Market Forecasts and Analysis
9.1.3 North America Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.1.4 North America Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.1.5 North America Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Aneurysm Therapeutics Market
9.1.5.1.1 United States Aneurysm Therapeutics Market by Type
9.1.5.1.2 United States Aneurysm Therapeutics Market by End User
9.1.5.2 Canada Aneurysm Therapeutics Market
9.1.5.2.1 Canada Aneurysm Therapeutics Market by Type
9.1.5.2.2 Canada Aneurysm Therapeutics Market by End User
9.1.5.3 Mexico Aneurysm Therapeutics Market
9.1.5.3.1 Mexico Aneurysm Therapeutics Market by Type
9.1.5.3.2 Mexico Aneurysm Therapeutics Market by End User
9.2. EUROPE
9.2.1 Europe Aneurysm Therapeutics Market Overview
9.2.2 Europe Aneurysm Therapeutics Market Forecasts and Analysis
9.2.3 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.2.4 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.2.5 Europe Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Aneurysm Therapeutics Market
9.2.5.1.1 Germany Aneurysm Therapeutics Market by Type
9.2.5.1.2 Germany Aneurysm Therapeutics Market by End User
9.2.5.2 France Aneurysm Therapeutics Market
9.2.5.2.1 France Aneurysm Therapeutics Market by Type
9.2.5.2.2 France Aneurysm Therapeutics Market by End User
9.2.5.3 Italy Aneurysm Therapeutics Market
9.2.5.3.1 Italy Aneurysm Therapeutics Market by Type
9.2.5.3.2 Italy Aneurysm Therapeutics Market by End User
9.2.5.4 Spain Aneurysm Therapeutics Market
9.2.5.4.1 Spain Aneurysm Therapeutics Market by Type
9.2.5.4.2 Spain Aneurysm Therapeutics Market by End User
9.2.5.5 United Kingdom Aneurysm Therapeutics Market
9.2.5.5.1 United Kingdom Aneurysm Therapeutics Market by Type
9.2.5.5.2 United Kingdom Aneurysm Therapeutics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Aneurysm Therapeutics Market Overview
9.3.2 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Aneurysm Therapeutics Market
9.3.5.1.1 Australia Aneurysm Therapeutics Market by Type
9.3.5.1.2 Australia Aneurysm Therapeutics Market by End User
9.3.5.2 China Aneurysm Therapeutics Market
9.3.5.2.1 China Aneurysm Therapeutics Market by Type
9.3.5.2.2 China Aneurysm Therapeutics Market by End User
9.3.5.3 India Aneurysm Therapeutics Market
9.3.5.3.1 India Aneurysm Therapeutics Market by Type
9.3.5.3.2 India Aneurysm Therapeutics Market by End User
9.3.5.4 Japan Aneurysm Therapeutics Market
9.3.5.4.1 Japan Aneurysm Therapeutics Market by Type
9.3.5.4.2 Japan Aneurysm Therapeutics Market by End User
9.3.5.5 South Korea Aneurysm Therapeutics Market
9.3.5.5.1 South Korea Aneurysm Therapeutics Market by Type
9.3.5.5.2 South Korea Aneurysm Therapeutics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Aneurysm Therapeutics Market Overview
9.4.2 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Aneurysm Therapeutics Market
9.4.5.1.1 South Africa Aneurysm Therapeutics Market by Type
9.4.5.1.2 South Africa Aneurysm Therapeutics Market by End User
9.4.5.2 Saudi Arabia Aneurysm Therapeutics Market
9.4.5.2.1 Saudi Arabia Aneurysm Therapeutics Market by Type
9.4.5.2.2 Saudi Arabia Aneurysm Therapeutics Market by End User
9.4.5.3 U.A.E Aneurysm Therapeutics Market
9.4.5.3.1 U.A.E Aneurysm Therapeutics Market by Type
9.4.5.3.2 U.A.E Aneurysm Therapeutics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Aneurysm Therapeutics Market Overview
9.5.2 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Aneurysm Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Aneurysm Therapeutics Market
9.5.5.1.1 Brazil Aneurysm Therapeutics Market by Type
9.5.5.1.2 Brazil Aneurysm Therapeutics Market by End User
9.5.5.2 Argentina Aneurysm Therapeutics Market
9.5.5.2.1 Argentina Aneurysm Therapeutics Market by Type
9.5.5.2.2 Argentina Aneurysm Therapeutics Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANEURYSM THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. GENERAL ELECTRIC COMPANY
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TERUMO CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JOTEC GMBH
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. COOK
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LIFETECH SCIENTIFIC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LOMBARD MEDICAL LIMITED
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CARDINAL HEALTH
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MEDTRONIC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. W. L. GORE AND ASSOCIATES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. GENERAL ELECTRIC COMPANY
2. Terumo Corporation
3. JOTEC GmbH
4. Cook
5. Lifetech Scientific
6. Lombard Medical Limited
7. Cardinal Health
8. Pfizer Inc.
9. Medtronic
10. W. L. Gore & Associates
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For